

Learn about common and serious Darunavir side effects, who's at higher risk, how to manage them, and when you should contact your doctor right away.
Every medication comes with potential side effects, and Darunavir (brand name Prezista) is no exception. The good news is that most people tolerate Darunavir well — it's considered one of the better-tolerated HIV protease inhibitors. But knowing what to watch for can help you manage your treatment with confidence.
This guide covers the most common side effects from FDA labeling, the serious reactions to be aware of, who may be at higher risk, and practical tips for managing symptoms.
Darunavir is an HIV protease inhibitor used to treat HIV-1 infection. It's always taken with a pharmacokinetic booster — either Ritonavir (Norvir) or Cobicistat (Tybost) — along with other antiretroviral medications. It's available as brand-name Prezista and as a generic. For a full overview of the medication, see our guide on what Darunavir is and how it works.
These side effects are reported frequently in clinical trials and are usually mild to moderate. Most improve within the first few weeks of treatment:
These are less common but require immediate medical attention. Contact your doctor or go to the emergency room if you experience any of the following:
While mild rash is common, Darunavir can in rare cases cause severe skin reactions including:
Call your doctor immediately if you develop a rash with fever, blistering, mouth sores, eye redness or swelling, or peeling skin.
Darunavir can cause drug-induced liver injury. Symptoms to watch for include:
Your doctor will monitor your liver function with regular blood tests, especially during the first several months of treatment.
Protease inhibitors including Darunavir can cause new-onset or worsening diabetes mellitus and hyperglycemia. Tell your doctor if you notice increased thirst, frequent urination, or unexplained weight loss.
When you start antiretroviral therapy and your immune system begins recovering, it may trigger an inflammatory response to pre-existing infections. This is called IRIS. Symptoms vary depending on the underlying infection but can include fever, swollen lymph nodes, and worsening of previous symptoms.
Darunavir is processed by the liver. People with mild-to-moderate hepatic impairment (Child-Pugh Class A or B) should use it with caution and have more frequent liver monitoring. Darunavir is contraindicated in severe hepatic impairment (Child-Pugh Class C).
Darunavir contains a sulfonamide moiety. If you have a known sulfonamide allergy, tell your doctor before starting this medication. While cross-reactivity is not always predictable, your provider should weigh the risks.
Darunavir is classified as FDA pregnancy category C. It should only be used during pregnancy if the benefit clearly outweighs the risk. Breastfeeding is generally not recommended for people living with HIV due to the risk of transmitting the virus to the infant.
Patients co-infected with hepatitis B or C may be at increased risk for liver complications while on Darunavir. The combination product Symtuza carries a boxed warning about the risk of hepatitis B flares after discontinuation.
Here are practical steps to help minimize Darunavir's common side effects:
Darunavir is generally well-tolerated, and most side effects are mild and manageable. The key is knowing what to watch for so you can catch any serious reactions early. Never stop your HIV medication without consulting your doctor — doing so can lead to drug resistance and make future treatment more difficult.
If you're experiencing side effects and want to explore your options, talk to your provider. And if you need help finding Darunavir at an affordable price, visit Medfinder to compare pharmacies and savings options near you.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.